营销状况和品牌药物价格:从Rx到OTC开关的证据
Health economics
|February 17, 2025
概括
在从处方药转向非处方药 (OTC) 状态后,品牌药物价格大幅下降. 这种价格下降与患者在OTC市场上价格敏感度增加有关,这表明需要对处方药的价格意识提高.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 市场分析市场分析
背景情况:
- 品牌药物定价是一个复杂的问题,受市场动态的影响.
- 处方到非处方 (Rx到OTC) 的切换代表了药品市场的重大转变.
- 了解转换后的定价行为对于政策和消费者福利至关重要.
研究的目的:
- 调查营销地位变化对品牌药物价格的影响.
- 分析Rx到OTC转换后的价格动态.
- 确定推动制药市场价格变化的因素.
主要方法:
- 采用了一种堆叠差异差异 (DiD) 研究设计.
- 分析了2001年至2016年期间发生的Rx-to-OTC转换的数据.
- 对诸如专利到期和仿制药进入等混变量进行控制.
主要成果:
- 品牌药物的零售价格在Rx转换为OTC后大幅下降.
- 观察到的价格下降主要归因于OTC市场患者价格弹性增加.
- 在考虑到专利到期和仿制药竞争后,结果仍然强.
结论:
- 转换Rx到OTC导致品牌药物的价格大幅降低.
- 患者价格敏感度增加是OTC市场价格降低的主要驱动因素.
- 政策干预应考虑提高患者的价格敏感性,以管理不断上升的处方药费用.
相关概念视频
Drug Nomenclature
1.6K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.6K
Prescription, Nonprescription and Orphan Drugs
681
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
681
Bioequivalence: Overview
910
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
910
Drug Classes and Categories
1.9K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
1.9K
Drug Biotransformation: Overview
2.3K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.3K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K


